APA (7th ed.) Citation

Yucel, S., & Bilgin, B. (2021). The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer. Journal of Oncology Pharmacy Practice, 27(1), 71. https://doi.org/10.1177/1078155220913106

Chicago Style (17th ed.) Citation

Yucel, Sebnem, and Burak Bilgin. "The Prognostic Values of Systemic Immune-inflammation Index and Derived Neutrophil-lymphocyte Ratio in EGFR-mutant Advanced Non-small Cell Lung Cancer." Journal of Oncology Pharmacy Practice 27, no. 1 (2021): 71. https://doi.org/10.1177/1078155220913106.

MLA (9th ed.) Citation

Yucel, Sebnem, and Burak Bilgin. "The Prognostic Values of Systemic Immune-inflammation Index and Derived Neutrophil-lymphocyte Ratio in EGFR-mutant Advanced Non-small Cell Lung Cancer." Journal of Oncology Pharmacy Practice, vol. 27, no. 1, 2021, p. 71, https://doi.org/10.1177/1078155220913106.